Reviews
Year :
2023
| Month :
March
| Volume :
17
| Issue :
3
| Page :
VE01 - VE06
Full Version
Cognition and Functional Recovery in Severe Mental Disorders-A Narrative Review
Published: March 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/59557.17638
J Jane Rinita, Suvarna Jyothi Kantipudi
1. Postgraduate Student, Department of Psychiatry, SRIHER, Chennai, Tamil Nadu, India.
2. Associate Professor, Department of Psychiatry, SRIHER, Chennai, Tamil Nadu, India.
Correspondence Address :
Dr. Suvarna Jyothi Kantipudi,
F-30, Staff Quarters, SRMC College Campus, Porur, Chennai-600116, Tamil Nadu, India.
E-mail: suvarna.srmc@gmail.com
Abstract
Severe Mental Illness (SMI) like schizophrenia and mood disorders has a prolonged and strenuous course which takes a major toll on the lives of the patients. In an effort to understand the consequence of these illness functional recovery has been studied in detail in the past. Cognitive impairment has been identified as an important contributor to the functional recovery. Cognitive impairment is an important component, independent of the symptoms, of SMI. Various cognitive deficits are found to occur in patients with SMI. Patients with lesser cognitive deficits were found to have better outcomes. This narrative review explains about cognitive impairment and functional outcome in people with SMI and the existing evidence for the relationship between both. Authors had performed manual search strategy of PubMed, Google Scholar engines for relevant research publications and reviewed them along with cross references from the retrieved articles. A broad review on the research shows, cognitive impairment has been recognised in both patients with schizophrenia and bipolar disorder even during periods of symptomatic remission and that people with symptomatic recovery continued to have functional deficits. This review also showed that patient with lesser cognitive deficits had better outcomes. Keeping this in mind, cognitive rehabilitation should be made a part of the management of SMI to achieve complete functional recovery.
Keywords
Neurocognition, Psychiatric disorders, Remission
The Severe Mental Illness (SMI) in psychiatry involves a range of mental illnesses, of which psychotic disorders and mood disorders form a major part (1). People with SMI experience many obstacles on their path to recovery leading to lifelong disability and functional impairment (2). Recovery in SMI is a dynamic concept, which contributes significantly to societal and economic burden, when disrupted. Recovery is no longer seen as clinical improvement alone, but as a holistic approach, where the aim is to help individuals with SMI live independently and reintegrate into the society. Un-remitting symptoms, treatment failure, co-existing medical illness, cognitive deficits, lack of insight, lack of psychosocial support are some of the factors contributing to the disability (3). The role of cognition in recovery has made it a key area of focus in psychiatric conditions. Impairment in cognition has been found to occur in SMI like schizophrenia and mood disorders. While looking at cognition in SMI, a number of factors relating to the symptoms, prognosis and management have come to light. A review of previous literature on the role of cognition in SMI, concept of functional recovery in SMI and the relationship between cognitive impairment and functional recovery has been presented in this article.
Literature search: Manual search was performed in PubMed, Google Scholar and other relevant publications were reviewed by the authors. The search terms used in PubMed were cognitive impairment AND schizophrenia OR Bipolar disorder, Functional recovery AND schizophrenia OR Bipolar disorder. Obtained articles were filtered based on the title and abstract by searching the electronic databases. Around 200 articles were retrieved based on clinical relevance and cross reference from the articles. A total of 69 articles were reviewed by both the authors (Table/Fig 1).
What is Cognition?
Cognition in essence refers to acquiring, understanding, and processing of information (4). It entails many conscious (as well as unconscious) mental activities like attention, working memory, execution, learning, problem solving, judgement, insight, etc., (5). Many of the cognitive functions are unique to the human species (6). The neural correlation of cognition is attributed to the sustained firing of neurons in the Dorsolateral Prefrontal Cortex (DLPFC) (7). Functional imaging studies have made it possible to understand how certain cognitive functions are related to specific regions of the cerebral cortex (6). Cognition is a highly complex ensemble of activities which interacts with affective domain as well. The state of cognition influences emotional well-being and similarly affective changes do influence the cognitive status (6),(8).
Assessment of cognition: Evaluation of cognitive functions is essential to identify the domains affected and the cortical regions involved in the disorder causing cognitive disturbances. Many tools have been introduced over the years to screen for cognitive impairment (9).
Mini Mental State Examination (MMSE): MMSE is a widely used tool for cognitive assessment by clinicians. It can be administered in <10 minutes and it is scored out of 30. It tests attention, orientation, verbal fluency, memory, abstraction. Lesser weightage is given testing visuospatial skills (10).
Montreal Cognitive Assessment (MoCA): MoCA is scored out of 30, and it tests visuospatial skills, executive function, memory, verbal fluency, attention, abstraction. MoCA has a higher sensitivity in detecting MCI (11).
Adden brooke’s Cognitive Examination (ACE) III: ACE-III covers a wide range of cognitive domains including attention, calculation, executive functions, verbal fluency, language, memory. It is scored out of 100 and a score of 88 is the cut-off. It takes about 20-30 minutes more than other screening tools (12).
Various neuropsychological tests are used to assess individual domains of cognition (Table/Fig 2) (13),(14),(15),(16),(17),(18),(19),(20),(21),(22),(23).
Cognition in Severe Mental Illness (SMI)
Cognitive impairment is a term used to describe abnormalities in any of the multiple domains of cognition (5). Some areas of cognitive impairment present in SMI range from inattention, difficulty in concentrating, working memory deficits, visuospatial deficits etc., (6). Cognitive deficits have been identified in schizophrenia, even before the onset of psychotic symptoms (24). Moderate to severe impairments have been found to co-occur during the first episode of psychosis (24). Impairment in attention, verbal learning and memory, verbal fluency, executive function has been identified in schizophrenia (5). Over the years, researchers have determined that cognitive deficits persisted in individuals with schizophrenia who were in remission (25). Research has confirmed that after statistical adjustment for Positive and Negative Symptoms Scale (PANSS) and IQ scores, patients with schizophrenia continued to have cognitive deficits (26). Recent studies have also shown cognitive impairment in patients with bipolar disorder, particularly in the areas of attention, executive function, and verbal memory during remission (5),(27). The severity of cognitive impairment correlates with number and severity of the episodes (27).
While looking at why cognitive deficits in SMI are important, authors come to understand that cognitive impairment plays an important role in determining the functional outcome of SMI making it an important component of treatment.
The Road to Recovery
What functional recovery means has been a sector of active research over many years. According to various researchers, psychosocial well-being has been explained as independence and living a meaningful life (28). Independence in terms of taking charge of their personal needs of daily living, medications, and their finance (28). Additionally, being able to find a job or return to work and receive remuneration for their work is also a part of psychosocial well-being. A person who has recovered from a psychiatric illness should be in a position to effectively communicate with others, live as a part of a family, integrate into community and fulfill their age appropriate role in the society with the least impact of the illness on the patient, the family and the community (26),(29).
Investigations into the details of what hampers functional recovery in patients with SMI, a multifold of elements have come into light (30). Environmental agents, history of substance use, familial support have been found to have a role in predicting functional recovery (31),(32). However, neurocognition, negative symptoms and personalised stigma towards the illness have stood out among the determinants (33).
Functional Recovery in Severe Mental Illness (SMI)
My whole mental power has disappeared, I have sunk intellectually below the level of a beast” (a patient with schizophrenia, quoted by Kraepelin, 1919, p. 25) (34).
Schizophrenia is a complex and SMI which is chronic, heterogeneous, and incapacitating. The remission in Schizophrenia Working Group defined symptomatic remission in schizophrenia as “the state in which the patient shows improvement in signs and symptoms, to such an extent that they do not interfere significantly in their behavior, and they are below the diagnostic threshold” (35). Advances in therapeutic approaches have made it possible today to help patients with schizophrenia achieve symptomatic remission (36). Nevertheless, schizophrenia remains to be one of the top 10 causes of disability and causes a high degree of global burden, making functional recovery an important area to be addressed in the future (29).
Functional recovery in schizophrenia is a multi-dimensional theory which entails personal, social, interpersonal, occupational domains (36). Studies have found that the patients with schizophrenia have difficulty in acquiring and maintaining jobs, establishing social relationships, and living independently [24,37,38]. Bipolar disorder was initially thought to be an episodic illness with inter-episodic premorbid level functioning. However, recent studies have shown that patients with bipolar disorder do not achieve their premorbid psychosocial functioning even during remission (39),(40),(41). Bipolar disorder patients continue have deficits in various domains of functional recovery.
Assessment of Functional Impairment
Several tools are used worldwide to assess functional impairment. The commonly used tools are:
WHO Disability Assessment Scale (WHODAS) 2.0 (42): WHO Disability Assessment Scale 2.0 is a reliable instrument developed by World Health Organisation (WHO) that can be used across cultures to assess disability. There are 2 versions, a self-administered 36 item score and a shorter 12 item version that can be administered in 5 minutes. It covers six domains, and each domain is scored between 0 and 4 (42).
Indian Disability Evaluation and Assessment Scale (IDEAS) (43): The Indian Disability Evaluation and Assessment Scale (IDEAS) were introduced by Indian Psychiatric Society in 2001. Self-care, interpersonal activities, communication, and work are the 4 areas assessed in IDEAS. Each area is scored between 0 and 4 (43).
Global Assessment of Functioning (GAF) (44): GAF scale was developed to rate Axis 5 of DSM 4. It is a 100-point scale that is rated by clinicians. Significant weightage is given to symptoms in GAF, which can lead to biases in scoring. Individuals with persistent symptoms might score lesser despite good functioning (44).
WHO Quality of Life (WHOQOL) (45): WHO has developed WHOQOL to assess the quality of life. This instrument helps to capture many subjective aspects of quality of life among patients. 2 versions WHOQOL 100 and WHOQOL BREF are available. WHOQOL 100 gives scores of individual facets (positive feelings, support etc.,) while WHODAS BREF gives scores of the domains (psychological, social, and physical) (45),(46).
Social and Occupational Functioning Scale (SOFAS) (47): SOFAS was designed to rate Axis 5 of DSM 4. It is scored between 0-100, lower scores denote lower level of functioning. It differs from GAF by focusing on functioning rather than individual symptoms (47),(48).
Relationship between Cognitive Deficits and Functional Outcome
Multiple studies have proved that patients with schizophrenia had deficits in cognitive domains that have translated to disabilities in life activities and participation (49)[,50]. Association between verbal memory and living either independently or in a community has been found (51). Deficits in language, visuospatial ability, verbal memory has been associated with performing activities of daily living (51). Associations between attention and performing life skills and work performance have been identified (51). Similarly, patients with bipolar affective disorders during their euthymic states continued to live with occupational and social impairment (52). The neurocognitive domains affected in patients with bipolar disorders during euthymic phase includes impairments in executive functions, attention deficits, working memory (52),(53). Research has shown associations between psychosocial functioning and verbal memory, attention deficits as well (38). The (Table/Fig 3) below summarises the findings of different studies involving cognitive deficits and functional outcome in schizophrenia and bipolar patients in the last two decades (54),(55),(56),(57),(58),(59),(60),(61),(62),(63),(64),(65),(66),(67).
With this in mind, cognitive remediation therapy has become a focus of patient rehabilitation. Cognitive remediation therapy has been defined as “a behavioral training-based intervention that aims to improve cognitive processes (attention, memory, executive function, social cognition, or metacognition) with the goal of durability and generalisation” (68). It uses simple tasks and exercises that were found to have a huge effect in improving cognitive functions in people with mental illness (69).
Conclusion
A high proportion of patients with SMI have persisting disability and poor quality of life. This is a matter of concern, as it adds significantly to the global burden. From review of research, it can be understood that people with SMI continue to have cognitive deficits inspite of symptomatic recovery. And the significant role of cognitive impairment in the functional recovery of patients with SMI like schizophrenia and bipolar disorder has been identified. Consequently, it can be concluded that targeting cognitive enhancement will go a long way in the rehabilitation and reintegration of patients with schizophrenia and bipolar disorders into the society.
1. | Johnson DL. Overview of severe mental illness. Clin Psychol Rev. 1997;17:247-57. Availble from: https://doi.org/10.1016/S0272-7358(97)00017-2. [crossref] [PubMed]
|
2. | Viron MJ, Stern TA. The impact of serious mental illness on health and healthcare. Psychosomatics. 2010;51:458-65. Available from: https://doi.org/10.1016/S0033-3182(10)70737-4. [crossref] [PubMed]
|
3. | Berghöfer A, Martin L, Hense S, Weinmann S, Roll S. Quality of life in patients with severe mental illness: A cross-sectional survey in an integrated outpatient health care model. Quality of Life Research. 2020;29:2073-87. Availble from: https://doi.org/10.1007/s11136-020-02470-0. [crossref] [PubMed]
|
4. | Dhakal A, Bobrin BD. Cognitive Deficits. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
|
5. | Millan MJ, Agid Y, Brüne M, Bullmore ET, Carter CS, Clayton NS, et al. Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov. 2012;11:141-68. Available from: https://doi.org/10.1038/nrd3628. [crossref] [PubMed]
|
6. | Pessoa L. On the relationship between emotion and cognition. Nat Rev Neurosci. 2008;9:148-58. Available from: https://doi.org/10.1038/nrn2317. [crossref] [PubMed]
|
7. | Fuster JM, Alexander GE. Neuron activity related to short-term memory. Science. 1971;173:652-54. Available from: https://doi.org/10.1126/science.173.3997.652. [crossref] [PubMed]
|
8. | Harmer CJ, O’Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A, et al. Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry. 2009;166:1178-84. Available from: https://doi.org/10.1176/appi.ajp.2009.09020149. [crossref] [PubMed]
|
9. | Gonzalez Kelso I, Tadi P. Cognitive Assessment. Treasure Island (FL): StatPearls Publishing; 2021.
|
10. | Folstein MF, Folstein SE, McHugh PR. Mini-mental state. J Psychiatr Res. 1975;12:189-98. Available from: https://doi.org/10.1016/0022-3956(75)90026-6. [crossref] [PubMed]
|
11. | Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-99. Available from: https://doi.org/10.1111/j.1532-5415.2005.53221.x. [crossref] [PubMed]
|
12. | Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s Cognitive Examination III in Frontotemporal Dementia and Alzheimer’s Disease. Dement Geriatr Cogn Disord. 2013;36:242-50. Available from: https://doi.org/10.1159/000351671. [crossref] [PubMed]
|
13. | Kaplan E, Googlass H, Weintraub S. Boston Naming Test (2nd edit.) Philadelphia. Estados Unidos: Lea y Febiger; 1983.
|
14. | Benton AL, Hamsher K, Sivan AB. Multilingual Aphasia Examination. 3rd ed. Iowa City, IA: AJA Associates; 1994.
|
15. | Hodges JR. Cognitive Assessment for Clinicians. 2nd ed. NY: OUP Oxford; 2007.
|
16. | Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50(1-3):07-15. Availble from: https://doi.org/10.1016/0010-0277(94)90018-3. [crossref] [PubMed]
|
17. | Berg EA. A simple objective technique for measuring flexibility in thinking. J Gen Psychol. 1948;39:15-22. Available from: https://doi.org/10.1080/00221309.1948.9918159. [crossref] [PubMed]
|
18. | Scorpio KA, Islam R, Kim SM, Bind R, Borod JC, Bender HA. Paired-associate learning. Encyclopedia of clinical neuropsychology, Cham: Springer International Publishing; 2018. Available from: https://doi.org/10.1007/978-3-319-57111-9_1137. [crossref]
|
19. | Bean J. Rey Auditory Verbal Learning Test, Rey AVLT. Encyclopedia of Clinical Neuropsychology, New York, NY: Springer New York; 2011. Available from: https://doi.org/10.1007/978-0-387-79948-3_1153. [crossref]
|
20. | Buschke H. Cued recall in Amnesia. J Clin Neuropsychol. 1984;6(4):433-40. Available from: https://doi.org/10.1080/01688638408401233. [crossref] [PubMed]
|
21. | Wambach D, Lamar M, Swenson R, Penney DL, Kaplan E, Libon DJ. Digit Span. Encyclopedia of Clinical Neuropsychology, New York, NY: Springer New York; 2011. Available from: https://doi.org/10.1007/978-0-387-79948-3_1288. [crossref]
|
22. | Huettel SA, McCarthy G. What is odd in the oddball task? Neuropsychologia. 2004;42(3):379-86. Available from: https://doi.org/10.1016/j.neuropsychologia.2003.07.009. [crossref] [PubMed]
|
23. | McDonald S, Flanagan S, Rollins J, Kinch J. TASIT: A new clinical tool for assessing social perception after traumatic brain injury. Journal of Head Trauma Rehabilitation 2003;18(3):219-38. Available from: https://doi.org/10.1097/00001199-200305000-00001. [crossref] [PubMed]
|
24. | Bowie CR, Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat. 2006;2:531-36. Available from: https://doi.org/10.2147/nedt.2006.2.4.531. [crossref] [PubMed]
|
25. | Kalkstein S, Hurford I, Gur RC. Neurocognition in Schizophrenia. Curr Top Behav Neurosci. 2010;4:373-90. Available from: https://doi.org/10.1007/7854_2010_42. [crossref] [PubMed]
|
26. | Keefe RSE, Poe M, Walker TM, Harvey PD. The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. J Clin Exp Neuropsychol. 2006;28:260-69. Available from: https://doi.org/10.1080/13803390500360539. [crossref] [PubMed]
|
27. | Carvalho AF, Bortolato B, Miskowiak K, Vieta E, Köhler C. Cognitive dysfunction in bipolar disorder and schizophrenia: A systematic review of meta-analyses. Neuropsychiatr Dis Treat. 2015;17:3111-25. Available from: https://doi.org/10.2147/NDT.S76700. [crossref] [PubMed]
|
28. | Yildiz M. Recovery as a process in severe mental illnesses. Noro Psikiyatr Ars. 2015;52:01-03. Available from: https://doi.org/10.5152/npa.2015.0120148. [crossref] [PubMed]
|
29. | Kwakernaak S, Swildens WE, Tom, van Wel F, Richard, Janssen TJM. Symptomatic and functional remission in young adults with a psychotic disorder in a rehabilitation focused team. Community Ment Health J. 2020;56:549-58. Available from: https://doi.org/10.1007/s10597-019-00512-7. [crossref] [PubMed]
|
30. | Torrey Fuller E. Surviving schizophrenia: A manual for families, consumers, and providers. 4th ed. New York: Quill; 2001.
|
31. | Albert N, Bertelsen M, Thorup A, Petersen L, Jeppesen P, le Quack P, et al. Predictors of recovery from psychosis analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr Res. 2011;125:257-66. Available from: https://doi.org/10.1016/J.SCHRES.2010.10.013. [crossref] [PubMed]
|
32. | Lambert M, Karow A, Leucht S, Schimmelmann BG, Naber D. Remission in schizophrenia: Validity, frequency, predictors, and patients’ perspective 5 years later. Dialogues Clin Neurosci 2010;12:393. Available from: https://doi.org/10.31887/DCNS.2010.12.3/MLAMBERT. [crossref] [PubMed]
|
33. | Cella M, Edwards C, Wykes T. A question of time: A study of time use in people with schizophrenia. Schizophr Res. 2016;176:480-84. Available from: https://doi.org/10.1016/J.SCHRES.2016.06.033. [crossref] [PubMed]
|
34. | O’Carroll R. Cognitive impairment in schizophrenia. Advances in Psychiatric Treatment. 2000;6:161-68. Available from: https://doi.org/10.1192/apt.6.3.161. [crossref]
|
35. | Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441-49. Available from: https://doi.org/10.1176/appi.ajp.162.3.441. [crossref] [PubMed]
|
36. | Silva MA, Restrepo D. Functional recovery in schizophrenia. Revista Colombiana de Psiquiatria (English Ed) n.d.; 48:252-60. Available from: https://doi.org/10.1016/j.rcp.2017.08.004. [crossref] [PubMed]
|
37. | Harvey PD. Functional recovery in schizophrenia: Raising the bar for outcomes in people with schizophrenia. Schizophr Bull. 2009;35:299. Available from: https://doi.org/10.1093/schbul/sbn186. [crossref] [PubMed]
|
38. | Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry. 2006;67(Suppl 9):03-08. [crossref]
|
39. | Gilbert E, Marwaha S. Predictors of employment in bipolar disorder: A systematic review. J Affect Disord. 2013;145:156-64. Available from: https://doi.org/10.1016/j.jad.2012.07.009. [crossref] [PubMed]
|
40. | Bonnín CM, Sánchez-Moreno J, Martínez-Arán A, Solé B, Reinares M, Rosa AR, et al. Subthreshold symptoms in bipolar disorder: Impact on neurocognition, quality of life and disability. J Affect Disord. 2012;136:650-59. Available from: https://doi.org/10.1016/j.jad.2011.10.012. [crossref] [PubMed]
|
41. | Volkert J, Kopf J, Kazmaier J, Glaser F, Zierhut KC, Schiele MA, et al. Evidence for cognitive subgroups in bipolar disorder and the influence of subclinical depression and sleep disturbances. European Neuropsychopharmacology. 2015;25:192-202. Available from: https://doi.org/10.1016/j.euroneuro.2014.07.017. [crossref] [PubMed]
|
42. | Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organisation disability assessment schedule 2.0. Bull World Health Organ. 2010;88:815-23. https://doi.org/10.2471/BLT.09.067231. [crossref] [PubMed]
|
43. | Thara R. IDEAS (Indian Disability Evaluation and Assessment Scale)—a scale for measuring and quantifying disability in mental disorders. India: The Indian Psychiatric Society; 2002.
|
44. | Aas IM. Guidelines for rating Global Assessment of Functioning (GAF). Ann Gen Psychiatry. 2011;10:2. Available from: https://doi.org/10.1186/1744-859X-10-2. [crossref] [PubMed]
|
45. | The Whoqol Group. The World Health Organisation quality of life assessment (WHOQOL): Development and general psychometric properties. Soc Sci Med 1998;46:1569-85. Availble from: https://doi.org/10.1016/S0277-9536(98)00009-4. [crossref] [PubMed]
|
46. | THE WHOQOL GROUP TW. Development of the World Health Organisation WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551-58. Available from: https://doi.org/10.1017/S0033291798006667. [crossref] [PubMed]
|
47. | Saraswat N, Rao K, Subbakrishna DK, Gangadhar BN. The Social Occupational Functioning Scale (SOFS): A brief measure of functional status in persons with schizophrenia. Schizophr Res. 2006;81(2-3):301-09. Available from: https://doi.org/10.1016/j.schres.2005.09.008. [crossref] [PubMed]
|
48. | Rybarczyk B. Social and Occupational Functioning Assessment Scale (SOFAS). In: Kreutzer Jeffrey S. and DeLuca J and CB, editor. Encyclopedia of Clinical Neuropsychology, New York, NY: Springer New York; 2011, Pp. 2313. Available from: https://doi.org/10.1007/978-0-387-79948-3_428. [crossref]
|
49. | Corigliano V, de Carolis A, Trovini G, Dehning J, di Pietro S, Curto M, et al. Neurocognition in schizophrenia: From prodrome to multi-episode illness. Psychiatry Res. 2014;220:129-34. Available from: https://doi.org/10.1016/J.PSYCHRES.2014.07.067. [crossref] [PubMed]
|
50. | Malla A. The role of cognition in outcome in schizophrenia and related disorders. Can J Psychiatry. 2014;59:03-04. Available from: https://doi.org/10.1177/070674371405900102. [crossref] [PubMed]
|
52. | Rajji TK, Miranda D, Mulsant BH. Cognition, function, and disability in patients with schizophrenia: A review of longitudinal studies. Can J Psychiatry. 2014;59:13-17. Available from: https://doi.org/10.1177/070674371405900104. [crossref] [PubMed]
|
52. | Bourin M. Cognitive impact in bipolar disorder. Arch Depress Anxiety. 2019;5(2):052-058. Available from: https://doi.org/10.17352/2455-5460.000042. [crossref]
|
53. | Vöhringer PA, Barroilhet SA, Amerio A, Reale ML, Alvear K, Vergne D, et al. Cognitive impairment in bipolar disorder and schizophrenia: A systematic review. Front Psychiatry. 2013;4:87. Available from: https://doi.org/10.3389/FPSYT.2013.00087. [crossref] [PubMed]
|
54. | Huang YC, Lee Y, Lee CY, Lin PY, Hung CF, Lee SY, et al. Defining cognitive and functional profiles in schizophrenia and affective disorders. BMC Psychiatry. 2020;20(1):39. Availble from: https://doi.org/10.1186/s12888-020-2459-y. [crossref] [PubMed]
|
55. | Valencia M, Fresán A, Barak Y, Juárez F, Escamilla R, Saracco R. Predicting functional remission in patients with schizophrenia: A cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome. Neuropsychiatr Dis Treat. 2015;11:2339-48. Available from: https://doi.org/10.2147/NDT.S87335. [crossref] [PubMed]
|
56. | Jain M, Singh S, Dalal P, Nischal A, Tripathi A, Kar S. A cross-sectional study of cognitive functions and disability in schizophrenia from a tertiary care hospital inxs North India. Medical Journal of Dr DY Patil University. 2016;9:457-64. Available from: https://doi.org/10.4103/0975-2870.186056. [crossref]
|
57. | Santosh S, Dutta Roy D, Kundu PS. Psychopathology, cognitive function, and social functioning of patients with schizophrenia. East Asian Arch Psychiatry. 2013;23:65-70.
|
58. | Krishnadas R, Moore BP, Nayak A, Patel RR. Relationship of cognitive function in patients with schizophrenia in remission to disability: A cross-sectional study in an Indian sample. Ann Gen Psychiatry. 2007;6:19. Available from: https://doi. org/10.1186/1744-859X-6-19. [crossref] [PubMed]
|
59. | Jiménez-López E, Sánchez-Morla EM, López-Villarreal A, Aparicio AI, Martínez- Vizcaíno V, Vieta E, et al. Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia. A five-year follow-up. Eur Psychiatry. 2019;56:60-68. Available from: https://doi.org/10.1016/J. EURPSY.2018.11.008. [crossref] [PubMed]
|
60. | Norlin Bagge E, Esbjörnsson E, Sunnerhagen KS. Cognitive screening and behavioural observation of functional ability in patients with multiple episode schizophrenia: An exploratory study. BMJ Open 2017;7(6):e014783. Available from: https://doi.org/10.1136/bmjopen-2016-014783. [crossref] [PubMed]
|
61. | Joseph J, Kremen WS, Franz CE, Glatt SJ, van de Leemput J, Chandler SD, et al. Predictors of current functioning and functional decline in schizophrenia. Schizophr Res. 2017;188:158-64. Available from: https://doi.org/10.1016/J. SCHRES.2017.01.038. [crossref] [PubMed]
|
62. | Leifker FR, Bowie CR, Harvey PD. Determinants of everyday outcomes in schizophrenia: The influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res. 2009;115:82-87. Available from: https://doi. org/10.1016/J.SCHRES.2009.09.004. [crossref] [PubMed]
|
63. | Zhu Y, Womer FY, Leng H, Chang M, Yin Z, Wei Y, et al. The relationship between cognitive dysfunction and symptom dimensions across schizophrenia, bipolar disorder, and major depressive disorder. Front Psychiatry. 2019;10:253. Available from: https://doi.org/10.3389/fpsyt.2019.00253. [crossref] [PubMed]
|
64. | Altshuler LL, Bearden CE, Green MF, van Gorp W, Mintz J. A relationship between neurocognitive impairment and functional impairment in bipolar disorder: A pilot study. Psychiatry Res. 2008;157:289-93. Available from: https:// doi.org/10.1016/J.PSYCHRES.2007.01.001. [crossref] [PubMed]
|
65. | Goswami U, Sharma A, Khastigir U, Ferrier IN, Young AH, Gallagher P, et al. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry. 2006;188:366-73. Available from: https://doi.org/10.1192/BJP.188.4.366. [crossref] [PubMed]
|
66. | Deng M, Pan Y, Zhou L, Chen X, Liu C, Huang X, et al. Resilience and cognitive function in patients with schizophrenia and bipolar disorder, and healthy controls. Front Psychiatry. 2018;9:279. Available from: https://doi.org/10.3389/ fpsyt.2018.00279. [crossref] [PubMed]
|
67. | Belvederi Murri M, Respino M, Proietti L, Bugliani M, Pereira B, D’Amico E, et al. Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes. J Affect Disord. 2019;257:166-72. Available from: https://doi. org/10.1016/J.JAD.2019.07.052 [crossref] [PubMed]
|
68. | Benedict RHB, Harris AE, Markow T, McCormick JA, Nuechterlein KH, Asarnow RF. Effects of attention training on information processing in schizophrenia. Schizophr Bull. 1994;20:537-46. Available from: https://doi.org/10.1093/ schbul/20.3.537. [crossref] [PubMed]
|
69. | Medalia A, Aluma M, Tryon W, Merriam AE. Effectiveness of attention training in schizophrenia. Schizophr Bull. 1998;24:147-52. Available from: https://doi. org/10.1093/oxfordjournals.schbul.a033306. [crossref] [PubMed]
DOI and Others DOI: 10.7860/JCDR/2023/59557.17638
Date of Submission: Aug 08, 2022 Date of Peer Review: Oct 06, 2022 Date of Acceptance: Nov 16, 2022 Date of Publishing: Mar 01, 2023
AUTHOR DECLARATION: • Financial or Other Competing Interests: None • Was Ethics Committee Approval obtained for this study? No • Was informed consent obtained from the subjects involved in the study? No • For any images presented appropriate consent has been obtained from the subjects. No
PLAGIARISM CHECKING METHODS: • Plagiarism X-checker: Aug 13, 2022 • Manual Googling: Oct 12, 2022 • iThenticate Software: Nov 08, 2022 (18%)
ETYMOLOGY: Author Origin
JCDR is now Monthly and more widely Indexed .
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase
- EBSCOhost
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Google
- Popline (reproductive health literature)
- www.omnimedicalsearch.com
|